NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study

Effect of NKG2D ligand expression on host immune responses

(2015) Marine Champsaur et al.   IMMUNOLOGICAL REVIEWS

COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients

(2010) Johanna G. H. van Nes et al.   BREAST CANCER RESEARCH AND TREATMENT

The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer

(2010) E. M. de Kruijf et al.   CLINICAL CANCER RESEARCH

ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients

(2010) Roger W. McGilvray et al.   INTERNATIONAL JOURNAL OF CANCER

NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting

(2009) R. W. McGilvray et al.   CLINICAL CANCER RESEARCH

ULBP6/RAET1L is an additional human NKG2D ligand

(2009) Robert A. Eagle et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

An integrated view of the regulation of NKG2D ligands

(2009) Noam Stern-Ginossar et al.   IMMUNOLOGY

Cellular Expression, Trafficking, and Function of Two Isoforms of Human ULBP5/RAET1G

(2009) Robert A. Eagle et al.   PLoS One

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

(2008) Kui Li et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy

(2008) Nadia Guerra et al.   IMMUNITY